5 posts on this topic, sorted most recent first.
Singapore is more expensive but more predictable. Bangkok is cheaper but more variable. The right choice depends on your trip length, risk tolerance, and whether you're optimizing for a single visit or a relationship.
MOH Circular 87/2024 hit its one-year anniversary in March; the in-person-consultation rule is now observable, not theoretical. Foundayo (orforglipron) HSA pathway tracking 12-18 months behind FDA. Oral Wegovy 25mg HSA filing the more imminent question. What changed for SG readers since the April buyer's guide.
Bangkok is the regional anchor for legitimately-supplied tirzepatide and semaglutide in Southeast Asia. Flight matrices, clinic-relationship cadence, cold-chain transit, customs personal-use rules per origin country, and the four-versus-twelve-week supply math.
The Singapore GLP-1 clinic layer beyond the existing buyers guide. Per-clinic pricing for the four most-routable Singapore providers, MOH-licensed-product reality, the Wegovy-vs-Ozempic supply picture, and when the 2h20 Bangkok flight beats the local cost.
Chi Longevity, The Longevity GP, Siena Health, Noah, Ordinary Folk, Clifford Clinic. SGD pricing, MOH 87/2024 in-person-first rule, what the 11-signal rubric scores them on, and how expats actually pick.